Last Updated on November 11, 2024 by admin
Myfortic 360mg Introduction
Myfortic 360 Tablet belongs to a group of medicines called immunosuppressants. It is used with other medicines to prevent your body from rejecting an organ (such as a kidney, heart or liver) after a transplant. It works by supressing your body’s immune system, so that it does not attack the new organ.
The amount of Myfortic 360 Tablet you take and how often you take it depends on the type of transplant you have. Follow your doctor’s instructions on this. You should take it on an empty stomach, at least 1 hour before or 2 hours after a meal. Swallow it as a whole, do not crush, chew, or break it. Take the medicine regularly to get the maximum benefit and keep taking it even if you feel well. If you stop taking it, you may increase the chances of rejecting your transplanted organ. The treatment will continue for as long as you need it to prevent rejection.
The most common side effects are nausea, vomiting, diarrhea, stomach pain, headache, high blood pressure, and changes in the number of white blood cells. You may catch more infection than usual as medicine suppresses the immune system. There is also an increased risk of developing some cancers for this reason. To reduce your risk of skin cancer, limit your exposure to the sun and use sunscreen. There is a long list of potential side effects with this medicine. You should ask your doctor about them and what signs to look out for because some of them can be serious and need urgent medical attention.
Myfortic 360 Tablet can cause birth defects and abortion so do not take it if you are pregnant, planning to become pregnant or breastfeeding. You should talk to your doctor before taking this medicine if you have any signs of infection or if you have any unexpected bruising or bleeding. You should also let your healthcare team know all other medicines you are taking as they may affect, or be affected by, this medicine. You will have regular tests to check for any changes in the number of your blood cells and the amount of sugar and cholesterol in your blood.
USES OF Myfortic 360
Myfortic 360mg, also known by its generic name mycophenolate mofetil, is primarily prescribed to prevent organ rejection in patients who have undergone kidney, liver, or heart transplants. This medication plays an essential role in immunosuppressive therapy, ensuring the transplanted organ is accepted by the recipient’s body. By inhibiting the proliferation of T and B lymphocytes, key immune cells, Myfortic 360mg effectively diminishes the body’s immune response to the new organ, thereby reducing the risk of rejection.
Beyond its primary application, Myfortic 360mg is also utilized in various off-label capacities, particularly in the management of certain autoimmune diseases. For instance, it has shown efficacy in treating conditions such as lupus nephritis, a severe kidney inflammation caused by systemic lupus erythematosus (SLE). Additionally, some patients with rheumatoid arthritis, systemic vasculitis, or pemphigus vulgaris have benefited from its immunosuppressive effects.
Specific patient populations gain considerable advantage from Myfortic 360mg. Transplant recipients with high immunological risk, such as those with a history of previous transplant rejection or those undergoing a second transplantation, particularly benefit from this medication. It’s also noteworthy that Myfortic 360mg is sometimes preferred in certain demographics, such as pediatric transplant recipients, due to its favorable side-effect profile compared to other immunosuppressive agents.
Renal transplant patients form the largest group among those using Myfortic 360mg, but liver and heart transplant patients also benefit significantly from its use. Moreover, individuals dealing with refractory autoimmune disorders, where conventional therapies have failed or caused intolerable side effects, find Myfortic 360mg to be an effective alternative. Ultimately, the decision to use Myfortic 360mg , whether for its primary or off-label uses, hinges on a thoughtful assessment by healthcare professionals considering both benefits and potential risks specific to each patient’s medical scenario.
BENEFITS OF Myfortic 360MG
- In Prevention of organ rejection in transplant patients
Myfortic 360mg (mycophenolate mofetil) is a therapeutic agent predominantly used in transplant medicine to enhance the success of organ transplants by reducing the risk of rejection. It functions as an immunosuppressant, effectively lowering the activity of the immune system to prevent it from attacking the newly transplanted organ, thus ensuring its optimal integration and function within the recipient’s body.
The primary benefit of Myfortic 360mg lies in its ability to significantly mitigate the possibility of organ rejection, which is a major risk following transplant surgeries. Studies have demonstrated that patients receiving Myfortic 360mg alongside other immunosuppressants like cyclosporine and corticosteroids have higher rates of graft survival. This improved success rate translates directly to enhanced quality of life and long-term health prospects for transplant recipients.
Beyond its critical role in transplant medicine, Myfortic 360mg has also been recognized for its potential benefits in treating various autoimmune diseases. Conditions such as lupus nephritis, rheumatoid arthritis, and psoriasis, which involve an overactive immune response against the body’s own tissues, may see improvements with Myfortic 360mg therapy. By modulating the immune system, Myfortic 360mg helps in reducing the severity of symptoms and preventing flare-ups in these chronic conditions.
Another noteworthy benefit is its usage in certain dermatological conditions. Patients with severe, recalcitrant autoimmune skin diseases have also shown positive responses to Myfortic 360mg, suggesting its versatility in addressing immune-related disorders beyond organ transplantation. These additional benefits underscore the broad therapeutic applications of Myfortic 360mg, making it an invaluable tool in modern medicine.
Overall, Myfortic 360mg not only excels in prolonging the viability of transplanted organs but also offers promising avenues for managing various autoimmune and inflammatory diseases. Its capability to selectively suppress unwanted immune reactions while maintaining a reasonable safety profile makes it a cornerstone in both transplant medicine and the broader field of immunotherapy.
Medicinal Benefits of Myfortic 360
Myfortic 360mg, known generically as mycophenolate mofetil, is a cornerstone in transplant medicine. Its primary role lies in its ability to prevent organ rejection, crucial for patients undergoing organ transplantation. By working at a cellular level, Myfortic 360mg inhibits the proliferation of T and B lymphocytes, which are active participants in the body’s immune response. Specifically, it disrupts the synthesis of guanine nucleotides, essential for the growth of these immune cells. This immunosuppressive action mitigates the risk of the body rejecting a newly transplanted organ, thereby ensuring the longevity and functionality of the transplanted tissue.
Beyond its pivotal role in preventing organ rejection, Myfortic 360mg offers ancillary benefits that are instrumental in patient health. One of the significant advantages is its potential to reduce reliance on corticosteroids. Corticosteroids, while effective in managing immune responses, come with a litany of side effects when used long-term, including osteoporosis, hypertension, diabetes, and increased infection risk. By combining Myfortic 360mg with lower doses of corticosteroids, patients can achieve a balanced immune suppression with fewer adverse effects.
The reduction in corticosteroid dependency not only improves the patient’s quality of life but also contributes to better long-term health outcomes. For instance, minimizing corticosteroid use can significantly reduce the risk of complications such as bone density loss and metabolic disorders. This implies fewer hospitalizations and medical interventions, which is beneficial for both patients and healthcare systems.
Moreover, Myfortic 360mg’s ability to modulate the immune system has implications beyond transplantation. Research is ongoing into its potential applications in treating autoimmune diseases, where dampening an overactive immune response is desirable. This expands the medicinal benefits of Myfortic 360mg, making it a versatile tool in modern pharmacotherapy. Overall, Myfortic 360mg’s effective immunosuppression, coupled with its corticosteroid-sparing effect, establishes it as a valuable therapeutic agent in the medical field.
SIDE EFFECTS OF Myfortic 360
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Myfortic 360
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
- High blood pressure
- Decreased white blood cell count (neutrophils)
HOW TO USE Myfortic 360
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Myfortic 360 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Directions for Use Myfortic 360MG
Mycophenolate sodium (360mg) Myfortic 360 Tablet is usually taken as a tablet or capsule, with or without food. It is important to follow the dosage instructions provided by your healthcare professional. Do not crush or chew the tablets unless instructed to do so. If you have any questions about how to take this medication, consult your doctor or pharmacist.
Myfortic 360 Storage
Store Mycophenolate sodium (360mg) Myfortic 360 Tablet at room temperature, away from moisture and heat. Keep it out of reach of children and pets. Do not use this medication if it has expired or if the packaging is damaged.
Drug Warnings and Interactions
When considering the use of Myfortic 360mg (mycophenolate mofetil), it is crucial to be aware of several significant warnings. This medication is not suitable for everyone, and specific individuals must exercise caution or avoid it entirely. Patients with known allergies to mycophenolate mofetil or any component of Myfortic 360mg should not use this medication due to the risk of severe allergic reactions. Additionally, patients with certain pre-existing conditions, such as active gastrointestinal disease or severe renal impairment, may require adjustments to their dosage or may need to seek alternative treatments.
Myfortic 360mg is an immunosuppressant, which means it lowers the body’s immune system activity. While this is beneficial for preventing organ rejection in transplant recipients, it also poses a higher risk of infections. Patients using Myfortic 360mg should be vigilant about signs of infection and report any symptoms such as fever, sore throat, or unusual fatigue to their healthcare provider immediately. Also, due to its immunosuppressive action, there is an increased risk of developing lymphomas and other malignancies.
Various drug interactions can affect the safety and efficacy of Myfortic 360mg. Medications that interact with Myfortic 360mg include certain antacids and proton pump inhibitors, which can reduce its absorption. Additionally, co-administration with cholestyramine, an agent used to lower cholesterol, may significantly decrease the plasma concentration of the active metabolite of Myfortic 360mg. This could potentially reduce its effectiveness, underscoring the need for careful management.
Certain supplements and over-the-counter medications can also interfere with Myfortic 360mg. For instance, live vaccines should be avoided as they might not be effective and could cause infections in patients with weakened immune systems. Other compounds such as acyclovir and its derivatives, when taken with Myfortic 360mg, can increase the concentration of both drugs, necessitating close monitoring.
It is imperative for patients to inform their healthcare provider about all the medications, supplements, and herbs they are currently taking. This includes any recent changes to their regimen, as this helps in anticipating potential interactions. By maintaining open communication with their healthcare provider, patients can ensure their treatment with Myfortic 360mg remains as safe and effective as possible.
Myfortic 360 Drug Interactions
Mycophenolate sodium (360mg) Myfortic 360 Tablet may interact with certain medications, including antacids, antibiotics, and antiviral drugs. It is important to inform your doctor about all the medications you are taking to avoid any potential interactions.
Myfortic 360-Drug Interactions Checker List: Safety Advice
Use a drug-drug interactions checker or consult your healthcare professional for a comprehensive list of potential drug interactions with Mycophenolate sodium (360mg) Myfortic 360 Tablet. This will help ensure your safety and the effectiveness of your treatment.
Always follow your doctor’s instructions and seek medical advice if you have any concerns or questions about using Mycophenolate sodium (360mg).
HOW Myfortic 360 WORKS
Myfortic 360 Tablet is an immunosuppressant. It reduces the action of body’s own defence system (the immune system) and prevents rejection of the transplanted organ.
SAFETY ADVICE
warnings
Alcohol
SAFE
Consuming alcohol with Myfortic 360 Tablet does not cause any harmful side effects.
warnings
Pregnancy
CONSULT YOUR DOCTOR
Myfortic 360 Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
warnings
Breastfeeding
UNSAFE
Myfortic 360 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
warnings
Driving
SAFE
Myfortic 360 Tablet does not usually affect your ability to drive.
warnings
Kidney
SAFE IF PRESCRIBED
Myfortic 360 Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Myfortic 360 Tablet may not be needed in these patients. Please consult your doctor.
warnings
Liver
CONSULT YOUR DOCTOR
There is limited information available on the use of Myfortic 360 Tablet in patients with liver disease. Please consult your doctor.
CHILDREN CAUTION
UNSAFE
Myfortic 360 Tablet is not recommended for use in children and adolescents below 18 years.
Myfortic 360 Habit Forming :
Myfortic 360 Tablet is a non-habit-forming health supplement. It does not contain any addictive substances and can be safely used as part of your daily wellness routine.
expert advice
Your doctor has prescribed Myfortic 360 Tablet to stop your body from rejecting a transplanted organ (e.g. kidney, heart or liver).
- It may take 6 to 12 weeks for Myfortic 360 Tablet to start working. Keep taking it as prescribed.
- Take it with food to minimize possible side effects like nausea and stomach pain.
- It makes you more susceptible to getting infections. Avoid contact with people who have an infection and consult your doctor immediately if you develop a sore throat, high temperature or any other signs of infections.
- It may cause birth defects so birth control is required in females of reproductive age.
- Protect yourself from direct sunlight by wearing protective clothing and applying a sunscreen with a high sun protection factor (SPF).
- Your doctor may get regular blood tests done to monitor the levels of blood cells in your blood. Inform your doctor if you experience symptoms such as unexplained bruising or bleeding, sore throat, mouth ulcers, or fever.
FAQs ABOUT Myfortic 360MG
Q: What is Myfortic 360MG used for?
A: Myfortic 360mg TABLET is used alone or with other medicines containing ciclosporin and corticosteroids to stop the body’s immune system from rejecting a kidney transplant in transplanted individuals.
Q: What common side effects are seen with Myfortic 360MG?
A: The most common side effects associated with the use of Myfortic 360MG TABLET are bloating, constipation, indigestion, high blood pressure, anxiety, diarrhoea, pain in joints, and dizziness. Consult your doctor if any of the symptom worsens.
Q: Who should avoid taking Myfortic 360MG?
A: Myfortic 360MG TABLET is not recommended for use if you are allergic to mycophenolic acid, mycophenolate sodium, and mycophenolate mofetil. Myfortic 360MG TABLET is also not recommended for use in pregnant and breast-feeding women. Consult your doctor before taking Myfortic 360MG TABLET.
Q: How Myfortic 360MG works?
A: Myfortic 360MG TABLET belongs to immunosuppressants which reduces the action of the body’s own defense system (the immune system) and prevents rejection of the transplanted organ.
Q: What happens if I forget to take Myfortic 360MG dose?
A: You should take Myfortic 360MG TABLET immediately when you remember. If it is time for your next dose skip the missed dose and follow your regular dose schedule. Do not double the dose of Myfortic 360MG TABLET to match up your missed dose.
Q: Is Myfortic 360MG safe to use in children or elderly patients?
A: No, Myfortic 360MG TABLET is not recommended for use in children due to lack of data. It should be used with caution in elderly patients (aged 65 years and above) after consulting the doctor.
Q: Is Myfortic 360MG safe to use during pregnancy?
A: Myfortic 360MG TABLET is not recommended for use during pregnancy and in women planning to become pregnant. Women with childbearing potential should confirm with negative in pregnancy test and follow effective contraception before taking Myfortic 360MG TABLET to avoid birth defects and miscarriage. Consult your doctor before taking Myfortic 360MG TABLET.
REFERENCES:
- Giuseppe Orlando, Giuseppe Remuzzi, David F. Williams. Pharmacokinetics and Genomics of Immunosuppressive Drugs. Kidney Transplant, Bioengineering, and Regeneration; Kidney Transplantation in Regenerative Medicine Era. 2017. Page 429.
- Novartis. Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in May 2011] [Accessed on 8th August 2022] https://clinicaltrials.gov/ct2/show/NCT00251004
- Dela Golshayan, M Pascual, Bruno Vogt. Mycophenolic acid formulations in adult renal transplantation – update on efficacy and tolerability. NIH National Library of Medicine. National Center for Biotechnology Information. May 2009. [Accessed on 8th August 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690976
- Novartis Pharma GmbH. Electronic Medicines Compendium (EMC). [Revised in July 2021] [Accessed on 8th August 2022] https://www.medicines.org.uk/emc/files/pil.7793.pdf
- Concord Biotech Limited. Mofecon-S 540. [Accessed on 8th August 2022] https://www.concordbiotech.com/product-3/#1491386049532-0521ba85-12e0
There are no reviews yet.